These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15008845)

  • 1. Postprandial hypoglycaemia due to insulin lispro.
    Fujiwara M; Baba T; Neugebauer S; Hasegawa K; Hosoya E; Tanaka K; Shimada K; Yamada D; Watanabe T
    Diabet Med; 2004 Mar; 21(3):297-8. PubMed ID: 15008845
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: post-prandial hypoglycaemia due to insulin lispro or insulin aspart.
    Burden AC
    Diabet Med; 2004 Dec; 21(12):1373. PubMed ID: 15569146
    [No Abstract]   [Full Text] [Related]  

  • 3. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
    Mohn A; Matyka KA; Harris DA; Ross KM; Edge JA; Dunger DB
    Diabetes Care; 1999 Jan; 22(1):27-32. PubMed ID: 10333899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.
    Burge MR; Castillo KR; Schade DS
    Diabetes Care; 1997 Feb; 20(2):152-5. PubMed ID: 9118763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin.
    McCrimmon RJ; Frier BM
    Diabet Med; 1997 Nov; 14(11):929-36. PubMed ID: 9400916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-prandial administration of insulin lispro with a high fat meal minimizes risk of hypoglycaemia in Type 1 diabetes.
    McAulay V; Ferguson SC; Frier BM
    Diabet Med; 2004 Aug; 21(8):953-4. PubMed ID: 15270807
    [No Abstract]   [Full Text] [Related]  

  • 9. Early postprandial hypoglycemia following administration of lispro insulin.
    Strachan MW; Frier BM
    Diabetes Care; 1997 Jul; 20(7):1214-5. PubMed ID: 9203474
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of insulin Lispro in the control of late postprandial hypoglycemia: comparison with regular human insulin].
    Cotticelli G; Bartiromo D; Ciavattone A; Di Leva R; Porcaro G; Nascia S; Mastroianni M; Sannino C; Conti G
    Minerva Med; 2000; 91(7-8):147-52. PubMed ID: 11155463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.
    Deeb LC; Holcombe JH; Brunelle R; Zalani S; Brink S; Jenner M; Kitson H; Perlman K; Spencer M
    Pediatrics; 2001 Nov; 108(5):1175-9. PubMed ID: 11694699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing hypoglycaemia with insulin analogues.
    Heller S
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S31-6. PubMed ID: 12174321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes.
    Brunelle BL; Llewelyn J; Anderson JH; Gale EA; Koivisto VA
    Diabetes Care; 1998 Oct; 21(10):1726-31. PubMed ID: 9773738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
    Weyer C; Gottlieb A; Kim DD; Lutz K; Schwartz S; Gutierrez M; Wang Y; Ruggles JA; Kolterman OG; Maggs DG
    Diabetes Care; 2003 Nov; 26(11):3074-9. PubMed ID: 14578242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.
    Garg SK; Buse JB; Skyler JS; Vaughn DE; Muchmore DB
    Diabetes Obes Metab; 2014 Nov; 16(11):1065-9. PubMed ID: 24840317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of type 1 diabetes with insulin lispro during Ramadan.
    Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness of hypoglycaemia in diabetes.
    Burden AC
    Lancet; 1987 Nov; 2(8570):1267. PubMed ID: 2890872
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unawareness of hypoglycaemia during treatment with human insulin.
    Misra A
    Natl Med J India; 1992; 5(6):279-80. PubMed ID: 1490159
    [No Abstract]   [Full Text] [Related]  

  • 20. Human insulin hypoglycaemia unawareness.
    Teuscher A; Eggèr M
    Lancet; 1989 May; 1(8646):1072. PubMed ID: 2566013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.